CompletedPHASE1, PHASE2NCT01267994

A Clinical Trial of Anakinra for Steroid-Resistant Autoimmune Inner Ear Disease

Studying Sudden sensorineural hearing loss

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Andrea Vambutas
Principal Investigator
Andrea Vambutas, MD
Northwell Health
Intervention
Anakinra(drug)
Enrollment
13 target
Eligibility
13-75 years · All sexes
Timeline
20112014

Study locations (1)

Collaborators

National Institute on Deafness and Other Communication Disorders (NIDCD)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01267994 on ClinicalTrials.gov

Other trials for Sudden sensorineural hearing loss

Additional recruiting or active studies for the same condition.

See all trials for Sudden sensorineural hearing loss

← Back to all trials